Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,409 | 1,441 | 1,490 | 1,489 | 1,576 | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 |
| Expenses | 1,324 | 1,350 | 1,385 | 1,395 | 1,452 | 1,429 | 1,373 | 1,412 | 1,530 | 1,648 | 1,695 | 1,746 |
| Operating Profit | 85 | 92 | 106 | 94 | 124 | 133 | 136 | 131 | 149 | 159 | 169 | 133 |
| OPM % | 6% | 6% | 7% | 6% | 8% | 8% | 9% | 8% | 9% | 9% | 9% | 7% |
| Other Income | 10 | 10 | 10 | 9 | 12 | 13 | 16 | 15 | 17 | 18 | 21 | 20 |
| Interest | 24 | 24 | 25 | 25 | 25 | 26 | 27 | 27 | 29 | 31 | 33 | 33 |
| Depreciation | 55 | 57 | 59 | 60 | 63 | 62 | 64 | 66 | 69 | 73 | 76 | 78 |
| Profit before tax | 16 | 20 | 32 | 18 | 48 | 57 | 61 | 53 | 69 | 73 | 80 | 42 |
| Tax % | 12% | 31% | -5% | 19% | 19% | 19% | 16% | 20% | 19% | 21% | 20% | 21% |
| Net Profit | 15 | 14 | 34 | 14 | 39 | 46 | 51 | 42 | 56 | 58 | 64 | 33 |
| EPS in Rs | 1.22 | 1.15 | 2.79 | 1.20 | 3.24 | 3.83 | 4.29 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,733 | 2,011 | 2,131 | 2,273 | 2,871 | 3,069 | 3,779 | 4,558 | 5,625 | 6,136 | 6,892 | 7,229 |
| Expenses | 1,696 | 1,940 | 2,073 | 2,153 | 2,737 | 2,852 | 3,507 | 4,292 | 5,270 | 5,648 | 6,284 | 6,620 |
| Operating Profit | 37 | 71 | 58 | 120 | 134 | 217 | 273 | 266 | 355 | 488 | 608 | 610 |
| OPM % | 2.1% | 3.5% | 2.7% | 5% | 4.7% | 7% | 7% | 6% | 6% | 8% | 9% | 8% |
| Other Income | 8 | 7 | 8 | 11 | 17 | 21 | 31 | 46 | 40 | 48 | 71 | 76 |
| Interest | 17 | 19 | 28 | 50 | 47 | 55 | 66 | 83 | 96 | 103 | 120 | 126 |
| Depreciation | 10 | 11 | 12 | 59 | 75 | 88 | 119 | 182 | 224 | 250 | 283 | 295 |
| Profit before tax | 19 | 48 | 26 | 23 | 29 | 95 | 118 | 47 | 73 | 183 | 275 | 264 |
| Tax % | 52% | 40% | -65% | 48% | 94% | 34% | 20% | -6% | 11% | 18% | 20% | |
| Net Profit | 9 | 29 | 42 | 12 | 2 | 63 | 95 | 50 | 66 | 150 | 220 | 210 |
| EPS in Rs | 508.71 | 1,620.57 | 2,080.06 | 585.46 | 107.02 | 1,393.11 | 8.03 | 4.17 | 5.48 | 12.56 | 18.30 | 17.54 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 15% | 18% | 15% | 17% | ||
| Compounded Profit Growth | 37% | 28% | 66% | 18% | ||
| Stock Price CAGR | % | % | -5% | -14% | ||
| Return on Equity | 8% | 7% | 8% | 12% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.17 | 0.17 | 0.17 | 0.19 | 0.19 | 0.19 | 0.45 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 141 | 137 | 148 | 303 | 291 | 528 | 730 | 1,394 | 1,467 | 1,554 | 1,717 | 1,951 |
| Borrowings | 170 | 223 | 204 | 162 | 429 | 477 | 590 | 815 | 900 | 1,010 | 1,120 | 1,424 |
| Other Liabilities | 126 | 149 | 183 | 179 | 239 | 344 | 245 | 361 | 406 | 417 | 500 | 533 |
| Total Liabilities | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 |
| Fixed Assets | 67 | 77 | 81 | 83 | 377 | 419 | 517 | 799 | 1,138 | 1,242 | 1,296 | 1,595 |
| CWIP | 3 | 3 | 2 | 1 | 1 | 5 | 6 | 20 | 25 | 11 | 16 | 32 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 368 | 429 | 453 | 560 | 580 | 924 | 1,043 | 1,775 | 1,633 | 1,752 | 2,047 | 2,306 |
| Total Assets | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -19 | -17 | 34 | 32 | 147 | -7 | 3 | 170 | 90 | 144 | 540 | 496 |
| Cash from Investing Activity | -16 | -32 | -15 | -18 | -19 | -28 | -35 | -703 | 429 | -83 | -318 | -128 |
| Cash from Financing Activity | 67 | 35 | -29 | -1 | -83 | 90 | -6 | 440 | -170 | -198 | -228 | -256 |
| Net Cash Flow | 32 | -15 | -10 | 14 | 45 | 56 | -37 | -93 | 350 | -137 | -5 | 112 |
| Free Cash Flow | -35 | -35 | 19 | 32 | 125 | -37 | -51 | 56 | -78 | 61 | 482 | 373 |
| CFO/OP | -26% | -19% | 70% | 96% | 133% | 6% | 15% | 75% | 39% | 49% | 120% | 94% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Inventory Days | 84 | 82 | 76 | 76 | 78 | 101 | 113 | 112 | 117 | 111 | 106 | 99 |
| Days Payable | 34 | 29 | 25 | 27 | 31 | 37 | 22 | 30 | 27 | 21 | 24 | 22 |
| Cash Conversion Cycle | 51 | 53 | 51 | 51 | 48 | 65 | 91 | 82 | 91 | 92 | 83 | 79 |
| Working Capital Days | 16 | 12 | 14 | 13 | 8 | 25 | 46 | 100 | 58 | 58 | 54 | 49 |
| ROCE % | 11% | 19% | 13% | 12% | 9% | 13% | 10% | 5% | 7% | 10% | 13% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 40.41% | 40.45% | 40.39% | 40.39% | 40.39% | 40.39% | 40.33% | 40.32% | 40.29% | 40.29% | 40.22% | 40.19% |
| FIIs | 12.36% | 12.96% | 14.94% | 14.85% | 14.72% | 15.23% | 15.61% | 16.43% | 16.53% | 16.83% | 15.53% | 14.38% |
| DIIs | 25.50% | 25.19% | 22.47% | 22.17% | 27.98% | 25.66% | 26.19% | 26.03% | 26.51% | 26.58% | 27.82% | 29.95% |
| Public | 21.61% | 21.31% | 22.10% | 22.51% | 16.85% | 18.68% | 17.82% | 17.18% | 16.60% | 16.27% | 16.41% | 15.45% |
| Others | 0.12% | 0.10% | 0.10% | 0.08% | 0.07% | 0.05% | 0.05% | 0.05% | 0.05% | 0.04% | 0.04% | 0.04% |
| No. of Shareholders | 66,430 | 66,048 | 74,976 | 76,934 | 87,328 | 83,912 | 83,439 | 81,742 | 78,337 | 79,157 | 77,278 | 76,005 |
Fundamentals
Market Cap₹ 7,857 Cr.
Current Price₹ 654
Stock P/E37.3
Book Value₹ 165
ROCE12.6 %
ROE11.6 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)17%
Compounded Profit Growth (TTM)18%
Consolidated figures.
Valuation
Market capRs 7,855 Cr
Enterprise valueRs 8,817 Cr
P/E (TTM)37.32x
Price to book3.98x
Price to sales1.09x
EV / EBITDA12.85x
EV / EBIT22.56x
EV / sales1.22x
Price to cash flow15.85x
Earnings yield2.68%
P/E, 3-year average77.34x
P/B, 3-year average5.18x
P/E, 5-year average102.83x
P/B, 5-year average5.86x
Profitability
Operating margin (excl. other income)8.82%
Operating margin (incl. other income)9.85%
EBITDA margin9.49%
Pre-tax margin3.66%
Net profit margin2.91%
Net margin, latest quarter1.77%
ROE11.82%
ROCE12.65%
ROA6.02%
ROE, 3-year average8.38%
ROCE, 3-year average9.99%
ROA, 3-year average4.33%
ROE, 5-year average7.50%
ROCE, 5-year average9.19%
ROA, 5-year average3.89%
ROIC (approx.)10.61%
Tax rate20.24%
Other income / net worth3.57%
Growth
Sales growth (latest year)12.33%
Profit growth (latest year)46.12%
Sales CAGR, 3 years14.78%
Sales CAGR, 5 years17.56%
Profit CAGR, 3 years64.04%
Profit CAGR, 5 years28.03%
Sales growth QoQ0.82%
Profit growth QoQ-48.14%
Sales growth YoY (latest quarter)21.84%
Profit growth YoY (latest quarter)-21.67%
Per share
EPS (TTM)Rs 17.53
EPS (latest year)Rs 18.30
EPS (latest quarter)Rs 2.76
EPS, 3-year averageRs 12.11
EPS, 5-year averageRs 9.71
Book value per shareRs 164.54
Sales per shareRs 602.18
Cash flow per shareRs 41.28
Free cash flow per shareRs 31.07
Efficiency
Asset turnover1.75x
Fixed asset turnover4.32x
Inventory turnover3.83x
Inventory days95 days
Debtor days1 days
Debtors turnover255.66x
Creditor days22 days
Cash conversion cycle79 days
Working capital days49 days
Leverage
Total debtRs 1,424 Cr
Cash and bankRs 462 Cr
Net debtRs 962 Cr
Debt to equity0.72x
Net debt / EBITDA1.40x
Interest coverage3.09x
Current ratio (filing 2026-03-31)3.00x
Quick ratio (filing 2026-03-31)1.00x
Trade payables (filing 2026-03-31)Rs 307 Cr
Owners' fund to total sources50.23%
Debt to assets36.22%
Cash flow
Cash from Operating Activity (latest year)Rs 496 Cr
Cash from Investing Activity (latest year)Rs -128 Cr
Cash from Financing Activity (latest year)Rs -256 Cr
Net Cash Flow (latest year)Rs 112 Cr
Free cash flow (latest year)Rs 373 Cr
FCFE (approx.: FCF + change in debt)Rs 678 Cr
Cash from ops / profit, 5 years2.48x
Sales to cash flow13.91x
Statement figures
Net sales (TTM)Rs 7,229 Cr
Net sales (latest year)Rs 6,892 Cr
Sales (latest quarter)Rs 1,880 Cr
Operating profit excl. other income (latest year)Rs 608 Cr
Operating profit (latest quarter)Rs 133 Cr
Other income (TTM)Rs 76 Cr
EBITDA (TTM)Rs 686 Cr
PBDT (TTM)Rs 560 Cr
Profit before tax (TTM)Rs 264 Cr
Tax (latest year)Rs 56 Cr
Net profit (TTM)Rs 210 Cr
Net profit (latest year)Rs 220 Cr
Net profit (latest quarter)Rs 33 Cr
Depreciation (TTM)Rs 295 Cr
Depreciation (latest quarter)Rs 78 Cr
Interest (TTM)Rs 126 Cr
Cost of goods sold (latest year)Rs 5,297 Cr
Total expenditure (latest year)Rs 6,284 Cr
Total income (latest year)Rs 6,963 Cr
Share capitalRs 24 Cr
ReservesRs 1,951 Cr
Shareholders' fundsRs 1,975 Cr
Total assetsRs 3,933 Cr
Net blockRs 1,595 Cr
Capital work in progressRs 32 Cr
ReceivablesRs 27 Cr
InventoryRs 1,382 Cr
Other liabilitiesRs 533 Cr
Shares outstanding (crore)12.01
Ownership
Promoter holding40.19% (-0.13 in a year)
Promoter pledge flagYes, NSE list
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 37.3 is the lowest in its own 4.9-year history
(median 92.7, low 37.3, high 231.4).
P/B 3.98 is the lowest in 4.9 years (median 5.80).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | MEDPLUS | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +0.0% | -2.8% | +2.8 pts |
| 1 month | -2.8% | -6.8% | +4.0 pts |
| 3 months | -20.4% | -7.6% | -12.8 pts |
| 6 months | -22.1% | +0.4% | -22.5 pts |
| 1 year | -18.1% | -9.9% | -8.2 pts |
| 2 years | -3.6% | -13.6% | +9.9 pts |
| 3 years | -14.9% | +14.2% | -29.1 pts |
37 mutual fund schemes hold about ₹2,200 Cr.
Over three months 8 bought more and 6 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| ICICI Pru Healthcare Fund- | 4.15% | 290 | +43% |
| SBI ELSS Tax Saver Fund | 0.86% | 273 | +5% |
| Kotak Small Cap Fund | 1.22% | 241 | -1% |
| Nippon India Pharma Fund | 2.51% | 238 | -1% |
| Nippon India Multi Cap Fund | 0.30% | 170 | +1% |
| Franklin India Small Cap Fund | 1.08% | 159 | +1% |
| Nippon India Focused Fund | 1.63% | 141 | +3% |
| ICICI Pru Innovation Fund | 1.60% | 126 | +71% |
| Franklin India Flexi Cap Fund | 0.59% | 115 | +4% |
| ICICI Pru Aggressive Hybrid Fund(A | 0.19% | 98 | +29% |
| Invesco India Contra Fund | 0.36% | 74 | +1% |
| Bandhan Small Cap Fund | 0.17% | 58 | +74% |
| Nippon India Flexi Cap Fund | 0.31% | 30 | +2% |
| Kotak Pioneer Fund | 0.62% | 26 | -6% |
| iSIF Equity Ex-Top 100 Long-Short Fund | 1.00% | 25 | -26% |
| Franklin India Multi Asset Allocation Fund | 0.78% | 23 | +1% |
| Franklin India ELSS Tax Saver Fund | 0.29% | 18 | +3% |
| ICICI Pru Conservative Hybrid Fund | 0.51% | 17 | +100% |
| ICICI Pru Small Cap Fund | 0.14% | 13 | +101% |
| ICICI Pru Small Cap Fund | 0.14% | 13 | +101% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 0.51% | 13 | -3% |
| Nippon India Aggressive Hybrid Fund(M | 0.28% | 11 | +3% |
| ICICI Pru Retirement Fund-Hybrid Aggressive Plan | 0.70% | 9 | -2% |
| Bandhan Balanced Advantage Fund | 0.35% | 8 | +1% |
| Baroda BNP Paribas Health and Wellness Fund | 0.93% | 5 | -1% |
Red flags
F-score 6 of 8| explain | Promoter pledge (NSE list) Promoter shares on the NSE pledge list |
| look | On NSE surveillance On NSE surveillance: Pledge |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹1,880 Cr +21.8% vs Jun 2025.
Net profit ₹33 Cr -21.4%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Entero Healthcare Solutions Ltd | 7,681 | 59.5 | 10.5 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Pledge: stage 1
Quick answers
What is the market cap of Medplus Health Services Ltd?
Medplus Health Services Ltd (MEDPLUS) has a market capitalisation of Rs 7,857 Cr. at the 2026-10-01 close.
What is the P/E ratio of Medplus Health Services Ltd?
Medplus Health Services Ltd trades at a P/E of 37.3 on trailing twelve-month profit, at the 2026-10-01 close.
What were Medplus Health Services Ltd's latest quarterly results?
In the Jun 2026 quarter, Medplus Health Services Ltd sales was Rs 1,880 Cr (+21.8% vs Jun 2025) and net profit was Rs 33 Cr.
What is the 52-week high and low of Medplus Health Services Ltd?
The 52-week high is Rs 1,022.20 and the 52-week low is Rs 645.00.